extensive calcification, which would increase the risk of atheroembolic complications during operative procedures. The patients were 25 males and 21 females, ranging between 44 and 93 years of age (mean, 73±10 years). Hemodialysis was required in 6 patients (13%) due to chronic renal failure. In this series, 10 patients (22%) had a porcelain aorta (a totally calcified aorta). Although preoperative imaging obtained by CT revealed the extent and thickness of calcification of the ascending aorta, operative procedures were determined by intra-operative findings.
Surgical technique 2.2.1 Preparation
Under general cardiac anesthesia and monitoring, an 8-mm, gelatin-impregnated, woven Dacron graft (Gelweave; VASCUTEK®, a TERUMO company, Renfrewshire, UK) was sewn to the right axillary artery 17) . After median sternotomy, cardiopulmonary bypass (CPB) was installed via the right axillary artery with single venous drainage. A pulmonary vein vent was used to prevent potentially damaging distension during ventricular fibrillation. The body was cooled to 28°C for internal inspection of the ascending aorta during brief circulatory arrest. Gentle palpation of the ascending aorta provided three-dimensional spatial imaging of the calcified aorta during cooling. Epiaortic echocardiography was also used to obtain intimal imaging of the ascending aorta along aortotomy.
Brief circulatory arrest for internal inspection of the ascending aorta
At a core body temperature of 28°C, brief circulatory arrest was initiated to observe the intimal condition of the ascending aorta. The ascending aorta was opened at the optimal site, which was determined by gentle palpation and epiaortic echocardiography. An oblique (J-shaped) incision is usually used for AVR. When severe calcification involves the sinus of Valsalva, a longitudinal (I-shaped) incision or transection would be indicated (Fig. 1) ; a representative CT image of a calcified sinus of Valsalva is shown in Fig. 2 . A severely calcified sinus of Valsalva prevents surgeons from obtaining a satisfactory surgical field around the aortic annulus, even if the anterior wall of the ascending aorta is retracted through the usual oblique incision. Moreover, prosthetic valves cannot be passed through a calcified sinus of Valsalva due to the limited diameter caused by nearly-circumferential calcification and the height of the prosthesis. For these reasons, it is very important to extend the I-shaped aortic incision to the sinus of Valsalva toward the commissure between the right and non-coronary cusps. After opening the ascending aorta, the intima was directly observed to confirm the existence of fragile debris. When the calcified ascending aorta was clampable at a safe site with just only calcification but no fragile debris, simple AVR was indicated. When there was severe calcification and no lesion for aortic crossclamping, both AVR and ascending aorta replacement were indicated during circulatory arrest with selective cerebral perfusion.
Simple AVR
The calcified ascending aorta was safely crossclamped after internal inspection of the ascending aorta during brief circulatory arrest at moderate hypothermia. Systemic perfusion was commenced via the right axillary artery after aortic crossclamping. Re-warming of the body was then started. Antegrade tepid blood cardioplegia was selectively delivered to obtain diastolic cardiac arrest. For maintenance, retrograde tepid blood cardioplegia was infused every 20 to 30 minutes. When remnant fragile debris was detected on the proximal ascending aorta, it was gently peeled as far as possible before AVR. 
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Firstly, the aortic valves were sharply removed, and one-quarter of gauze was placed into the left ventricle (LV) to catch calcific debris. Decalcification was gently performed with Pean Hemostatic Forceps and Selman Tissue Forceps (Pilling®; Teleflex Medical, Tuttlingen, Germany) around the aortic annulus. The LV cavity was carefully irrigated with copious amounts of cold saline to reduce the risk of emboli. Secondly, a 2-0 polyfilament braided non-everting mattress suture with spaghetti (Matsuda-ika Kogyo, Tokyo, Japan) was placed for each commissure. Great attention is needed for commissural suturing between the right and non-coronary cusps. Deep stitches for the commissure would injure the conduction system, which would result in complete atrioventricular block. For patients with this complication, permanent pacemaker implantation would be necessary. Subsequently, sizing of the prosthetic valve was performed in accordance with each commercial sizer. When a bioprosthetic valve was selected, it was irrigated with saline for preparation. Thirdly, intercommissural sutures were placed for each coronary cusp. Independent of the type of prosthetic valve, 15 sutures, one for each commissure and four for each coronary cusp, were usually placed (Fig. 3) . Then, a total of 15 sutures was placed on the prosthetic annulus, and the appropriate valve was seated in the supravalvular position. 
Closure of a calcified ascending aorta
For patients with a non-calcified aortic wall, the ascending aorta is usually closed with 5-0 polypropylene continuous horizontal mattress and over-and-over sutures. However, for patients with a fragile aortic wall, the aortotomy was closed with 4-0 polyfilament braided www.intechopen.com horizontal mattress (Matsuda-ika Kogyo, Tokyo, Japan) and 5-0 polypropylene over-andover sutures (Prolene®; Ethicon, Somerville, NJ, USA) (Fig. 4A) . When the edges of the aortotomy included calcification, an endarterectomy was performed to facilitate closure of the ascending aorta. For patients with a severely calcified aorta, a knitted polyester strip of 2 cm in width (Sauvage Filamentous Fabric®; Bard Peripheral Vascular Inc., Tempe, AZ, USA) was used to prevent cutting and injury of the calcified ascending aorta. The left end of the strip was divided to place over the aortotomy. At first, 4-0 polyfilament braided horizontal mattress sutures were required for both ends to fix the trimmed strip. Other horizontal mattress sutures were placed along the aortotomy. Except for the two central sutures, all sutures were tied down (Fig. 4B) . Then, aortotomy closure was started with 5-0 polypropylene over-and-over sutures from both edges toward the central untied sutures (Fig. 4C) . The aortotomy between the two untied sutures (about 2 cm in length) was kept open to flush out the debris. Under low CPB flow, the ascending aorta was carefully declamped with manual occlusion of the neck vessels. A sufficient amount of blood was flushed out from the aortotomy for about 30 seconds (Fig. 4D) . Then, the two central sutures were tied down. The central portion of the aortotomy was reinforced with 5-0 polypropylene over-and-over suture.
AVR plus ascending aorta replacement
When simple AVR cannot be safely performed due to an unclampable ascending aorta, AVR plus ascending aorta replacement is selected for these patients. During circulatory arrest at a core body temperature of 28°C, cerebral perfusion was selectively initiated. Antegrade tepid blood cardioplegia was selectively delivered to obtain cardioplegic cardiac arrest. For maintenance, retrograde tepid blood cardioplegia was infused every 20 to 30 minutes. The ascending aorta was transected above the level of the sinotubular junction and subsequently transected below the level of the innominate artery. The prosthetic aortic valve was seated in the supravalvular position. The technical details of the AVR were described above. After seating the prosthetic valve, localized endarterectomy for the distal anastomosis was performed if needed. The distal end of the ascending aorta was encircled by a 2-cm-wide felt strip. A gelatin-impregnated, woven Dacron graft (J Graft SEALED NEO®; JUNKEN-MEDICAL Co., Japan Lifeline, Saitama, Japan) with one side branch was implanted as open distal anastomosis. It was sewn to the distal end of the ascending aorta with 4-0 polyfilament braided sutures in a horizontal mattress fashion (Fig. 5A) . The distal end of the Dacron graft (1 cm in length) was gently fixed in an inverted form (Fig. 5B) . Then, the anastomosis was reinforced with additional 3-0 polypropylene over-and-over suture (Fig. 5C) . After completion of the distal anastomosis, cerebral perfusion was withdrawn, and antegrade systemic perfusion was started via the side branch of the Dacron graft (Fig. 5D). www.intechopen.com The proximal anastomosis was completed by single 3-0 polypropylene running sutures. Firstly, the proximal end of the graft was sewn to the posterior wall of the proximal aorta with 3-0 polypropylene running suture. Then, both ends of the suture were tied with other 3-0 polypropylene sutures to avoid relaxation of the posterior anastomosis. Thus, the posterior wall of the graft was fixed in an inverted form (Fig. 6A) . Secondly, one stay suture was placed at the toe for easy adjustment (Fig. 6B) . Thirdly, the anterior wall of the graft was sewn to the proximal aorta with 3-0 polypropylene running sutures from both ends (Fig. 6C). 
Concomitant procedure
In combined coronary artery bypass grafting (CABG) and AVR procedures, distal anastomoses were completed without crossclamping during cooling. For beating CABG procedures, a heart retracting system with the Tentacles Heart Positioner (Sumitomo Bakelite, Tokyo, Japan), which provides excellent exposure of target coronary arteries 18) , is usually used. Proximal anastomoses were performed during single crossclamping after AVR. In combined mitral valve surgery and AVR, mitral valve plasty (MVP) or mitral valve replacement (MVR) was performed prior to AVR. For patients not requiring ascending aorta replacement, the ascending aorta was crossclamped after brief circulatory arrest. Subsequently, mitral valve surgery was initiated prior to AVR. For patients with ascending aorta replacement, the distal end of the ascending aorta was firstly sewn to a Dacron graft with one side branch during circulatory arrest (Fig. 6A) . After the distal anastomosis, systemic and cerebral perfusion was antegradely maintained via the side branch of the graft (Fig. 6B) . Then, mitral valve surgery was initiated prior to AVR. When the left side Maze procedure was indicated, it was performed via the right-sided left atriotomy during mitral valve surgery. After completion of mitral valve surgery, AVR was started as described above. Subsequently, the left atrium was closed and the proximal anastomosis of the ascending aorta was performed (Fig. 6C) . Finally, the right side Maze procedure and/or tricuspid valve surgery was performed through the right atriotomy.
Results
Of a total of 705 patients having AVR, 46 patients (11%) with a calcified ascending aorta required brief circulatory arrest for internal inspection of the ascending aorta. Of these 46 patients, 42 (92%) underwent simple AVR after safe aortic crossclamping. The duration of circulatory arrest was less than 1 min in 40 patients and the longest duration was 3 min (mean 0.9±0.6 min). In 3 patients (7%), AVR plus ascending aorta replacement was performed due to an unclampable ascending aorta during circulatory arrest at moderate hypothermia (28°C). For 1 patient (1%), the Bentall operation was done due to a dilated sinus of Valsalva. In this series, patients had AVR with a bioprosthetic (n=31; 67%) or a mechanical valve (n=15; 33%). Twenty-seven patients (59%) had concomitant procedures including CABG (n=18), MVR (n=6), MVP (n=2), the Maze procedure (n=4), and tricuspid annuloplasty (n=3). No intraaortic balloon pumping was required postoperatively. Aortic crossclamping time was 76±18 min. CPB time was 148±29 min. Operative time was 330±69 min. The hospital mortality was 2.2% (1 of 46). One patient died of gastrointestinal bleeding. There was no cardiogenic death in this series. The postoperative morbidity was 2.2% (1 of 46). Cerebrovascular accident occurred in one patient.
Discussion
Patients with AS and a calcified ascending aorta were treated with meticulous techniques. Careful maneuvers for calcified lesions would reduce atheroembolic complications, contributing to better surgical outcomes. The surgical challenge of dealing with patients with AS and calcified ascending aorta started in the 1980s 10, 11) . With advances in medical technology, the surgical strategy has been modified in various ways. Theoretically, the simplest approach is supposed to be AVR without aortic crossclamping during HCA [10] [11] [12] . Although the no-touch technique to the calcified aorta effectively reduces the surgical risk of atheroembolic events, prolonged HCA time is a risk for stroke 19) . As a different strategy to facilitate AVR, endarterectomy during HCA has been reported to avoid embolic events 13, 20) . No patients with postoperative stroke www.intechopen.com suggested a good early result, but there were no follow-up data relating to the long-term risks of aortic dissection or dilatation. Although HCA provides simple strategies for patients with AS and a calcified ascending aorta, technical modifications are needed to render the procedure less invasive. Aortic crossclamping is one of the most technically difficult aspects for patients with a calcified ascending aorta. The release of aortic crossclamping is closely associated with embolic events during cardiac surgery 9) . As an alternative for aortic crossclamping, a method of internal occlusion of the ascending aorta was reported; i.e., endoaortic balloon occlusion 15) . According to that report, a Foley catheter was directly introduced via the usual aortotomy during a brief period of circulatory arrest at a nasopharyngeal temperature of 25°C. Although the advantages of endoaortic balloon occlusion include easy preparation and less invasive technique, a retrospective analysis demonstrated that it was frequently ineffective and was associated with a significantly higher risk of in-hospital death and a numerically higher risk of stroke 21) . We used brief circulatory arrest less than 1 min in most cases at moderate hypothermia (28°C) for internal inspection of calcified ascending aorta. The extent and severity of calcification is directly observed, and the firmness of the calcified ascending aorta is also palpable without wall stress caused by afterload. Thus, in this situation, it is easy to determine whether the calcified ascending aorta is clampable. When the calcified ascending aorta is clampable, simple AVR followed by aortic crossclamping is planned as a less invasive operation. However, ascending aorta replacement would be performed for patients with an unclampable calcified ascending aorta. At moderate hypothermia (28°C), simple AVR could be converted into ascending aorta replacement under circulatory arrest with selective cerebral perfusion. Thus, patients with AS and calcified ascending aorta are surgically repaired by our strategy without deep HCA. A recent surgical report also demonstrated that short-term moderate hypothermic arrest is useful for safe aortic crossclamping after internal inspection of a bad ascending aorta 22) . Although this technique for safe crossclamping is almost the same as our strategy, all cases were treated with simple AVR followed by aortic crossclamping. The reason for this would include endarterectomy or debridement by the Cavitron ultrasonic surgical aspirator (CUSA) 23) , which successfully achieves a safe aortic crossclamping site. Therefore, circulatory arrest time was slightly longer (3.4±1.5 min) compared to ours (less than 1 min). Although small calcific particles created by the CUSA are potential causes of postoperative stroke, all of them would be completely aspirated. As a result, the postoperative stroke rate remained low (2.5%), with no mortality. For patients with a calcified ascending aorta, the CUSA would also be useful for removing calcific debris during AVR. As one of the alternatives for open heart surgery, transcatheter valve implantation (TAVI) had been newly developed for symptomatic patients at high risk or with contraindications for surgery 24) . A calcified ascending aorta would be a good indication for TAVI. Successful TAVI dramatically alleviates severe symptoms with a minimally-invasive method. However, TAVI involves major complications such as paravalvular leakage, valve malposition, coronary occlusion, annulus and aortic root rupture, atrioventricular block, and cerebrovascular events 25) . The 30-day all-cause mortality rate with the CoreValve Revalving System (Medtronic Inc.) ranges from 5.5% to 15.5%, while that with the Edwards Sapien prosthesis (Edwards Life Science Corporation) ranges from 6.3% to 10.3% 25) . Although the incidence of persistent neurological impairment was low (less than approximately 5%), the incidence of clinically silent peri-interventricular cerebral embolic lesions after TAVI was www.intechopen.com Aortic Stenosis -Etiology, Pathophysiology and Treatment 128 high 25, 26) . The results of TAVI would be improved by further development of medical devices, but current results are not far superior to our surgical outcomes. Accordingly, there is no established treatment for AS and calcified ascending aorta at present. In the future, prevalence of calcified lesions, including AS and calcified ascending aorta, is likely to increase as the average lifespan of populations increases. With the advances in medical technologies, new therapeutic technologies, such as TAVI, will be developed for safer strategies and to minimize invasiveness. However, TAVI is not the optimal treatment for all patients with AS, including patients requiring concomitant procedures such as CABG and mitral valve surgery. For these patients, conventional open heart surgery would be one of the therapeutic choices. Additionally, state-of-the-art technologies will not be available worldwide. Thus, cardiac surgeons should continue to modify their strategies by meticulous techniques and share their strategies for better outcomes. Addressing this surgical challenge would result in resolution for many more high-risk patients with complex calcified lesions.
Conclusion
Technical modifications such as right axillary artery cannulation and brief circulatory arrest at moderate hypothermia are useful for patients with AS associated with a calcified ascending aorta. The operative design would be important to minimize the surgical risk for such high-risk patients.
